» Articles » PMID: 37504973

Promising Natural Medicines for the Treatment of High-Altitude Illness

Overview
Date 2023 Jul 28
PMID 37504973
Authors
Affiliations
Soon will be listed here.
Abstract

Li Li, Lin Lin, Bo Wen, Peng-cheng Zhao, Da-sheng Liu, Guo-ming Pang, Zi-rong Wang, Yong Tan, and Cheng Lu. Promising natural medicines for the treatment of high-altitude illness. . 24:175-185, 2023.-High-altitude illness (HAI) is a dangerous disease characterized by oxidative stress, inflammatory damage and hemodynamic changes in the body that can lead to severe damage to the lungs, heart, and brain. Natural medicines are widely known for their multiple active ingredients and pharmacological effects, which may be important in the treatment of HAI. In this review, we outline the specific types of HAI and the underlying pathological mechanisms and summarize the currently documented natural medicines applied in the treatment of acute mountain sickness and high-altitude cerebral edema, high-altitude pulmonary edema, chronic mountain sickness, and high-altitude pulmonary hypertension. Their sources, types, and medicinal sites are summarized, and their active ingredients, pharmacological effects, related mechanisms, and potential toxicity are discussed. In conclusion, natural medicines, as an acceptable complementary and alternative strategy with fewer side effects and more long-term application, can provide a reference for developing more natural antialtitude sickness medicines in the future and have good application prospects in HAI treatment.

References
1.
Yu Z, Jin W, Dong X, Ao M, Liu H, Yu L . Safety evaluation and protective effects of ethanolic extract from maca (Lepidium meyenii Walp.) against corticosterone and HO induced neurotoxicity. Regul Toxicol Pharmacol. 2019; 111:104570. DOI: 10.1016/j.yrtph.2019.104570. View

2.
Yang Y, Wang Z, Gao S, Ren H, Zhong R, Chen W . The effects of Salvia przewalskii total phenolic acid extract on immune complex glomerulonephritis. Pharm Biol. 2017; 55(1):2153-2160. PMC: 6130473. DOI: 10.1080/13880209.2017.1383486. View

3.
Cui Y, Xin H, Tao Y, Mei L, Wang Z . Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway. Phytother Res. 2020; 35(2):974-986. DOI: 10.1002/ptr.6857. View

4.
Kosanovic D, Tian X, Pak O, Lai Y, Hsieh Y, Seimetz M . Rhodiola: an ordinary plant or a promising future therapy for pulmonary hypertension? a brief review. Pulm Circ. 2014; 3(3):499-506. PMC: 4070792. DOI: 10.1086/674303. View

5.
Di Ciaccio L, Spotorno V, Cordoba Estevez M, Rios D, Fortunato R, Salvat A . Antifungal activity of Parastrephia quadrangularis (Meyen) Cabrera extracts against Fusarium verticillioides. Lett Appl Microbiol. 2018; 66(3):244-251. DOI: 10.1111/lam.12844. View